SEC Filing Summary: India Globalization Capital, Inc. (IGC Pharma, Inc.)
Business Context and Reporting Period
This Form 8-K Current Report was filed on November 1, 2018, regarding events occurring on October 29, 2018. The registrant, India Globalization Capital, Inc., received notification from NYSE American LLC to commence delisting proceedings for its common stock. Trading in the Company's stock was suspended effective the market open on October 29, 2018.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on regulatory status and listing proceedings rather than financial performance data.
Material Changes
- Delisting Action: NYSE Regulation determined the Company has substantially discontinued its original business and is engaged in ventures that have not reached a commercial stage or are problematical.
- Public Interest Concern: The Exchange cited operations contrary to the public interest under Section 1003(f)(iii) of the Company Guide.
- Trading Suspension: Immediate suspension of trading was deemed necessary for investor protection.
Outlook, Management Commentary, and Risks
Management is evaluating three primary options: (a) challenging the NYSE decision through an appeal process, (b) applying to alternative U.S. exchanges such as the OTC markets, or (c) applying to a Canadian exchange for listing. The Company is actively pursuing the resumption of trading. An appeal requires a non-refundable fee of $10,000 for an oral hearing or $8,000 for a written submission, to be filed within seven calendar days of the notice.
Investor Verification Checklist
- Verify the current trading status of the stock on OTC markets or Canadian exchanges.
- Confirm whether the Company filed a formal appeal with NYSE American within the seven-day window.
- Review the attached press release (Exhibit 99.1) for additional details on the "ventures" cited by the Exchange.
- Check for subsequent filings regarding the outcome of the delisting appeal or new listing applications.